VEA
KRRO icon

Virtus ETF Advisers’s Korro Bio KRRO Stock Holding History

Virtus ETF Advisers’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-426
Closed -$150K – 392
2021
Q3 		$150K Sell
426
-22
-5% -$8.66K 0.07% 340
2021
Q2 		$223K Buy
448
+284
+173% +$139K 0.09% 267
2021
Q1 		$78K Buy
164
+3
+2% +$5.83K 0.03% 353
2020
Q4 		$284K Sell
161
-148
-48% -$195K 0.12% 236
2020
Q3 		$297K Sell
309
-43
-12% -$46.2K 0.16% 224
2020
Q2 		$409K Buy
+352
New +$318K 0.19% 189

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtus ETF Advisers's KRRO Position: Q4 2021 in Review

Virtus ETF Advisers sold out of Korro Bio (KRRO) in Q4 2021, closing a stake of 426 shares — an estimated $150K sold.

Virtus ETF Advisers first reported a position in KRRO in Q2 2020 and held it in 6 quarters. The position peaked at $409K in Q2 2020. 82 funds tracked by Wall St. Rank hold KRRO as of Q4 2021.

  • Virtus ETF Advisers reported no remaining Korro Bio position as of Q4 2021 after selling out during the quarter.
  • Virtus ETF Advisers sold 426 Korro Bio shares in Q4 2021, an estimated $150K.
  • Virtus ETF Advisers first reported a position in Korro Bio in Q2 2020 and held it in 6 quarters.
  • Virtus ETF Advisers's Korro Bio position peaked at $409K in Q2 2020.
  • 82 funds tracked by Wall St. Rank held Korro Bio as of Q4 2021.

Based on Virtus ETF Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.